A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, PK, and PD Effects of REGN2477-1033 in Obese Patients with Type 2 Diabetes Mellitus

Administered By

Awarded By

Contributors

Start/End

  • December 3, 2018 - May 12, 2020